MediWound Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Yevne Israel (2001)

Organization Overview

First Clinical Trial
2014
NCT02020746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

MediWound Ltd

Active Ingredients

Drugs in Phase 3 Trials (1)

bromelains (3 trials)

Drugs in Phase 2 Trials (1)

escharex (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Burns (Phase 3)

Leg Ulcer (Phase 2)

Surgical Wound (Phase 2)

Ulcer (Phase 2)

Varicose Ulcer (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 2